These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3258308)

  • 1. Biochemical and molecular properties of cisplatin-resistant A2780 cells grown in folinic acid.
    Lu Y; Han J; Scanlon KJ
    J Biol Chem; 1988 Apr; 263(10):4891-4. PubMed ID: 3258308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated expression of thymidylate synthase cycle genes in cisplatin-resistant human ovarian carcinoma A2780 cells.
    Scanlon KJ; Kashani-Sabet M
    Proc Natl Acad Sci U S A; 1988 Feb; 85(3):650-3. PubMed ID: 3422447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporin A suppresses cisplatin-induced c-fos gene expression in ovarian carcinoma cells.
    Kashani-Sabet M; Wang W; Scanlon KJ
    J Biol Chem; 1990 Jul; 265(19):11285-8. PubMed ID: 2113532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collateral sensitivity to novel thymidylate synthase inhibitors correlates with folate cycle enzymes impairment in cisplatin-resistant human ovarian cancer cells.
    Marverti G; Ligabue A; Paglietti G; Corona P; Piras S; Vitale G; Guerrieri D; Luciani R; Costi MP; Frassineti C; Moruzzi MS
    Eur J Pharmacol; 2009 Aug; 615(1-3):17-26. PubMed ID: 19446547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of cross-resistance to methotrexate and 5-fluorouracil in an A2780 human ovarian carcinoma cell subline resistant to cisplatin.
    Newman EM; Lu Y; Kashani-Sabet M; Kesavan V; Scanlon KJ
    Biochem Pharmacol; 1988 Feb; 37(3):443-7. PubMed ID: 3337743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells.
    Scanlon KJ; Newman EM; Lu Y; Priest DG
    Proc Natl Acad Sci U S A; 1986 Dec; 83(23):8923-5. PubMed ID: 3466165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of thymidylate synthase, dihydrofolate reductase, and DT-diaphorase gene expression in human tumors using the polymerase chain reaction.
    Horikoshi T; Danenberg KD; Stadlbauer TH; Volkenandt M; Shea LC; Aigner K; Gustavsson B; Leichman L; Frösing R; Ray M
    Cancer Res; 1992 Jan; 52(1):108-16. PubMed ID: 1727369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of azidothymidine cytotoxicity in cisplatin-resistant human ovarian carcinoma cells.
    Scanlon KJ; Funato T; Pezeshki B; Tone T; Sowers LC
    Cancer Commun; 1990; 2(10):339-43. PubMed ID: 1698426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms associated with the expression of cisplatin resistance in a human ovarian tumor cell line following exposure to fractionated X-irradiation in vitro.
    Dempke WC; Shellard SA; Hosking LK; Fichtinger-Schepman AM; Hill BT
    Carcinogenesis; 1992 Jul; 13(7):1209-15. PubMed ID: 1638688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribozyme-mediated cleavage of c-fos mRNA reduces gene expression of DNA synthesis enzymes and metallothionein.
    Scanlon KJ; Jiao L; Funato T; Wang W; Tone T; Rossi JJ; Kashani-Sabet M
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10591-5. PubMed ID: 1660142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collateral sensitivity to azidothymidine in methotrexate resistant human leukemia cells.
    Miyachi H; Jiao L; Sowers LC; Scanlon KJ
    In Vivo; 1992; 6(1):17-21. PubMed ID: 1385729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation(s) of the thymidylate synthase gene of human adenocarcinoma cells causes a thymidylate synthase-negative phenotype that can be attenuated by exogenous folates.
    Houghton PJ; Rahman A; Will CL; Dolnick BJ; Houghton JA
    Cancer Res; 1992 Feb; 52(3):558-65. PubMed ID: 1732043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms for cisplatin-FUra synergism and cisplatin resistance in human ovarian carcinoma cells both in vitro and in vivo.
    Scanlon KJ; Lu Y; Kashani-Sabet M; Ma J; Newman E
    Adv Exp Med Biol; 1988; 244():127-35. PubMed ID: 3247881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A human leukemia cell line made resistant to two folate analogues, trimetrexate and N10-propargyl-5,8-dideazafolic acid (CB3717).
    Takemura Y; Ohnuma T; Miyachi H; Sekiguchi S
    J Cancer Res Clin Oncol; 1991; 117(6):519-25. PubMed ID: 1683871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folate transport and the modulation of antifolate sensitivity in a methotrexate-resistant human breast cancer cell line.
    Dixon KH; Trepel JB; Eng SC; Cowan KH
    Cancer Commun; 1991; 3(12):357-65. PubMed ID: 16296001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of collateral sensitivity to cisplatin, methotrexate, and fluorouracil in a human ovarian carcinoma cell line following exposure to fractionated x-irradiation in vitro.
    Dempke WC; Hosking LK; Hill BT
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):66-72. PubMed ID: 1557659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased thymidylate synthase in L1210 cells possessing acquired resistance to N10-propargyl-5,8-dideazafolic acid (CB3717): development, characterization, and cross-resistance studies.
    Jackman AL; Alison DL; Calvert AH; Harrap KR
    Cancer Res; 1986 Jun; 46(6):2810-5. PubMed ID: 2938731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a cisplatin-resistant human ovarian carcinoma cell line expressing cross-resistance to 5-fluorouracil but collateral sensitivity to methotrexate.
    Hill BT; Shellard SA; Hosking LK; Dempke WC; Fichtinger-Schepman AM; Tone T; Scanlon KJ; Whelan RD
    Cancer Res; 1992 Jun; 52(11):3110-8. PubMed ID: 1591724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictions of a network thermodynamics computer model relating to the mechanism of methotrexate rescue by 5-formyltetrahydrofolate and to the importance of inhibition of thymidylate synthase by methotrexate-polyglutamates.
    White JC
    Adv Exp Med Biol; 1983; 163():305-26. PubMed ID: 6193692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of DNA replication and repair enzymes in cisplatin-resistant human colon carcinoma HCT8 cells and circumvention by azidothymidine.
    Scanlon KJ; Kashani-Sabet M; Sowers LC
    Cancer Commun; 1989; 1(4):269-75. PubMed ID: 2534792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.